Overview
Access
/time_series
data via our API — starting from the
Basic plan and above.
Description
HST Global Inc. is a company engaged in the research, development, promotion, and sale of novel therapies for life-threatening, unmet medical needs. Primarily, HST Global focuses on diseases that have inefficiencies and gaps in current treatment approaches. The firm's core mission is to address critical areas in healthcare by advancing innovative therapeutic solutions, predominantly targeting oncology and supportive care. With a strategic emphasis on research-driven growth, HST Global leverages cutting-edge science and technology to pioneer new treatment paradigms. The company plays a crucial role in the biomedical sector, collaborating with healthcare professionals, research institutions, and regulatory bodies to fast-track the development of effective medical interventions. HST Global's market significance lies in its potential to fill vital niche areas within the pharmaceutical and healthcare industries, thereby contributing to global efforts in managing and curing complex diseases. As the demand for specialized medical treatments grows, HST Global Inc. continues to align its operational strategies with ongoing advancements in medical research and development.
About
CEO
Mr. Michael P. Fortkort
Employees
—
Address
509 Old Neck Road
Suite 105
Virginia Beach, 23454, VA
United States
Suite 105
Virginia Beach, 23454, VA
United States
Phone
800 961 4750
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
PINX